Kayla Livingston
Papers
1
Total Citations
26
H-Index
1
About
Kayla Livingston is a clinical molecular biologist whose work has been instrumental in advancing real-time genomic surveillance of emerging viral pathogens. Her primary research focus lies in the development and validation of high-throughput next-generation sequencing (NGS) workflows for clinical laboratories, with a particular emphasis on SARS-CoV-2 whole genome sequencing. Her most cited paper, published in 2022, details the creation of a robust, scalable sequencing pipeline that enables the rapid monitoring of new mutations—a critical tool for identifying diagnostic and therapeutic targets during the COVID-19 pandemic. This work has garnered 26 citations, reflecting its immediate utility in guiding public health responses and informing vaccine and treatment strategies. By bridging the gap between cutting-edge sequencing technology and practical clinical application, Livingston has helped democratize access to genomic epidemiology. Her contributions underscore the vital role of clinical laboratories in pandemic preparedness, ensuring that actionable genomic data can be generated quickly to track viral evolution and inform control measures.
Research Focus
Key Achievements
Top Papers
- 1